Last reviewed · How we verify

NCT06573762

Home-Based Monitoring in Parkinson's Disease

Recruiting now Last updated 10 April 2025
What this trial tests

trial in Parkinson Disease in 120 participants. Currently enrolling.

Timeline
7 April 2025
Primary endpoint
1 January 2027
1 January 2028

Quick facts

Lead sponsorJacob E. Simmering
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment120
Start date7 April 2025
Primary completion1 January 2027
Estimated completion1 January 2028
Sites1 location across United States

Conditions studied

Sponsor

Jacob E. Simmering

Who can join

Adults 50 to 110, any sex, with Parkinson Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this observational study is to learn about the usefulness of automated analysis of speech, physical activity measures tracked using wearable devices at home, and tremor detection measured using computer-vision analysis of smartphone video to detect impairments related to Parkinson's disease and improve prediction of one-year progression. Participants will attend a short research visit at the University of Iowa. During this visit, they will make a video recording using a smartphone of them performing a fine motor task and audio recordings of pre-written text. They will be provided with an activity tracker and asked to wear it at home for four weeks. After four weeks, a video visit will be conducted and the speech and video tasks will be repeated.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Parkinson Disease

Currently open trials in the same condition.

Other Jacob E. Simmering trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06573762.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing